Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Trial of 68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High-Risk Meningiomas

NCT07353229 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT07353229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07353229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Trial of 68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High-Risk Meningiomas
Lead sponsor
Thomas Jefferson University
Phase
Phase 1
Overall status
Suspended
Start date
September 5, 2025
Completion date
September 30, 2028
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high risk meningioma, recurrent meningioma